Back
Sutro Biopharma, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
50
STRO
Sutro Biopharma, Inc.
Last Price:
$13.04
Seasonality Move:
-14.43%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atSutro Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Sutro Biopharma, Inc. has on average historically fallen by 14.1% based on the past 7 years of stock performance.
-
Sutro Biopharma, Inc. has fallen lower in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
-
Is Sutro Biopharma, Inc. Stock Undervalued?The current Sutro Biopharma, Inc. [STRO] share price is $11.75. The Score for STRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
STRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sutro Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Sutro Biopharma, Inc. has on average historically fallen by 14.1% based on the past 7 years of stock performance.
Sutro Biopharma, Inc. Stock Rating
Sell
50
Sutro Biopharma, Inc. (STRO)
is a Sell
Is Sutro Biopharma, Inc. overpriced?
-
Sutro Biopharma, Inc. has fallen lower in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
Sutro Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sutrobio.com
52-Week Data
52-Week High:
21.50
52-Week Low:
5.23
Prediction Charts
Market Cap:
100.1M
Price in USD:
11.75
Volume:
156K
Beta:
1.21
Technical Analysis
SMA50:
9.68
SMA100:
9.44
SMA200:
8.76
52-Wk Change:
-39.74%
Stock Predictions
-
Is Sutro Biopharma, Inc. stock public?Yes, Sutro Biopharma, Inc. is a publicly traded company.
-
What is the Sutro Biopharma, Inc. stock quote today?The Sutro Biopharma, Inc. stock price is 11.75 USD today.
-
How to buy Sutro Biopharma, Inc. stock online?You can buy Sutro Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 9.01 | 8.93 | 9.25 | 8.66 |
| Dec-19 | 8.94 | 9.98 | 10.15 | 8.49 |
| Dec-22 | 9.83 | 10.37 | 11.09 | 9.72 |
| Dec-23 | 10.31 | 10.38 | 10.61 | 10.09 |
| Dec-24 | 10.35 | 10.75 | 10.83 | 10.20 |
| Dec-26 | 10.75 | 11.49 | 12.00 | 10.73 |
| Dec-29 | 11.28 | 11.10 | 11.36 | 11.00 |
| Dec-30 | 11.12 | 11.67 | 11.92 | 11.03 |
| Dec-31 | 11.71 | 11.57 | 12.18 | 11.47 |
| Jan-2 | 11.50 | 10.96 | 11.74 | 10.60 |
| Jan-5 | 10.95 | 10.87 | 11.59 | 10.15 |
| Jan-6 | 10.78 | 11.52 | 11.52 | 10.78 |
| Jan-7 | 11.40 | 11.75 | 12.32 | 11.24 |
| Jan-8 | 11.70 | 11.75 | 11.99 | 11.14 |
Sutro Biopharma, Inc. Earnings
Sutro Biopharma, Inc. Earnings Report: Per Share Sutro Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sutro Biopharma, Inc. Forecast Revenue Growth
Sutro Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Sutro Biopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.59 per share, and an increase next year of $10.41 per share.
* Sutro Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.